CHU de Martinique, Pôle de Cancérologie Hématologie Urologie Pathologie, UF 1441 Registre Général des cancers de la Martinique, F-97200, Martinique, France.
French Network of Cancer Registries, F-31000, Toulouse, France.
BMC Cancer. 2020 Jul 10;20(1):643. doi: 10.1186/s12885-020-07128-1.
For the first time, we present regional-level cancer incidence and world-standardized mortality rates for cancers for Martinique, Guadeloupe and French Guiana.
For Martinique, Guadeloupe and French Guiana, incidence data come from population-based cancer registries, and cover the periods 2007-2014, 2008-2014 and 2010-2014 respectively. Standardized incidence and mortality rates were calculated using the world population.
In the 3 regions, all cancers combined represent 3567 new cases per year, of which 39.8% occur in women, and 1517 deaths per year (43.4% in women). Guadeloupe and Martinique present similar world-standardized incidence rates. Among gynaecological cancers, breast cancer, the second most common cancer type in the 3 regions, has an incidence rate 35 to 46% lower than in mainland France. On the other hand, cervical cancer has a higher incidence rate, particularly in French Guiana. For both endometrial cancer and ovarian cancer, no significant differences in incidence rates are found compared to mainland France. Regarding mortality, world-standardized mortality rates are similar between Guadeloupe and Martinique, and higher than in French Guiana. This situation compares favourably with mainland France (all cancers). Among gynaecological cancers, the mortality rate is lower for breast cancer in all regions compared to mainland France, and also lower for ovarian cancer in Martinique and Guadeloupe, but higher (albeit non-significantly) in French Guiana.
The ethno-geographic and socio-demographic characteristics in this population of mainly Afro-Caribbean origin could partially explain these disparities. Major disparities exist for certain cancer sites: excess incidence and excess mortality for cervical cancer; lower, but increasing incidence of breast cancer.
我们首次呈现了马提尼克岛、瓜德罗普岛和法属圭亚那的癌症发病率和按世界标准校正的死亡率的地区数据。
对于马提尼克岛、瓜德罗普岛和法属圭亚那,发病率数据来源于基于人群的癌症登记处,分别涵盖 2007-2014 年、2008-2014 年和 2010-2014 年的时间段。使用世界人口计算了标准化发病率和死亡率。
在这 3 个地区,所有癌症的总和每年有 3567 例新发病例,其中 39.8%发生在女性中,每年有 1517 例死亡(女性占 43.4%)。瓜德罗普岛和马提尼克岛的世界标准化发病率相似。在妇科癌症中,乳腺癌是这 3 个地区的第二大常见癌症类型,其发病率比法国大陆低 35%至 46%。另一方面,宫颈癌的发病率更高,特别是在法属圭亚那。子宫内膜癌和卵巢癌的发病率与法国大陆相比没有明显差异。在死亡率方面,瓜德罗普岛和马提尼克岛的世界标准化死亡率相似,高于法属圭亚那。与法国大陆(所有癌症)相比,这一情况较为有利。在妇科癌症中,所有地区的乳腺癌死亡率都低于法国大陆,马提尼克岛和瓜德罗普岛的卵巢癌死亡率也较低,但法属圭亚那的死亡率较高(尽管无统计学意义)。
该人群主要为非裔加勒比血统,其种族地理和社会人口学特征可能部分解释了这些差异。某些癌症部位存在较大差异:宫颈癌发病率和死亡率均较高;乳腺癌发病率较低,但呈上升趋势;卵巢癌发病率较低,但呈上升趋势。